SolyC

General Information


DRACP ID  DRACP02397

Peptide Name   SolyC

Sequence  FSGGNCRGFRRRCFCTK

Sequence Length  17

UniProt ID  K4CBP6 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
THP-1 Childhood acute monocytic leukemia; Acute monoblastic/monocytic leukemia Leukemia Not active up to 120 µg/ml Trypan blue assay 24, 48, 72 h 1

Hemolytic Activity  Human erythrocytes: HC50=270 µg/ml

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  DRACP02397

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C83H131N31O21S3

Absent amino acids  ADEHILMPQVWY

Common amino acids  R

Mass  228088

Pl  11.31

Basic residues  5

Acidic residues  0

Hydrophobic residues  3

Net charge  5

Boman Index  -6224

Hydrophobicity  -71.76

Aliphatic Index  0

Half Life 
  Mammalian: 1.1 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  125

Absorbance 280nm  7.81

Polar residues  9

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 23124812

Title  A novel synthetic peptide from a tomato defensin exhibits antibacterial activities against Helicobacter pylori

Doi 10.1002/psc.2462

Year  2012

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  DBAASPR_4545

DRACP is developed by Dr.Zheng's team.